{"id":"https://openalex.org/W2947198060","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","title":"Molecular profile of ampulla of vater carcinoma (AVC): A rare tumor type with meaningful molecular alterations.","display_name":"Molecular profile of ampulla of vater carcinoma (AVC): A rare tumor type with meaningful molecular alterations.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947198060","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","mag":"2947198060"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.4119","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068575845","display_name":"Jo\u00e3o Moreira-Pinto","orcid":"https://orcid.org/0000-0002-8981-3272","observed_orcids":["https://orcid.org/0000-0002-8981-3272"]},"institutions":[{"id":"https://openalex.org/I4210129048","display_name":"Hospital Beatriz \u00c2ngelo","ror":"https://ror.org/03kyy9y42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210129048"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Pinto","raw_affiliation_strings":["Oncology Division, Hospital Beatriz \u00c2ngelo, Loures, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Division, Hospital Beatriz \u00c2ngelo, Loures, Portugal;","institution_ids":["https://openalex.org/I4210129048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054454777","display_name":"Helena Verdaguer","orcid":"https://orcid.org/0000-0001-6163-382X","observed_orcids":["https://orcid.org/0000-0001-6163-382X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Helena Verdaguer","raw_affiliation_strings":["Vall d\u2019Hebron University Hospital Barcelona Spain y Vall d\u2019hebron insitute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital Barcelona Spain y Vall d\u2019hebron insitute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108984695","display_name":"Mar\u00eda Teresa Salcedo","orcid":"https://orcid.org/0000-0002-4822-5060","observed_orcids":["https://orcid.org/0000-0002-4822-5060"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Teresa Salcedo","raw_affiliation_strings":["Vall d\u2019Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036441583","display_name":"Anna Pedrola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Pedrola","raw_affiliation_strings":["Oncology Data Science Group, Vall D\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Data Science Group, Vall D\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038339156","display_name":"Jorge Hernando-Cubero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge Hernando-Cubero","raw_affiliation_strings":["Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Bracelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Bracelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049974461","display_name":"J.D. Assaf Pastrana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan David Assaf Pastrana","raw_affiliation_strings":["Vall d\u2019Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Acosta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Acosta","raw_affiliation_strings":["Vall d\u2019Hebron University Hospital Barcelona Spain y Vall d\u2019hebron insitute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital Barcelona Spain y Vall d\u2019hebron insitute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071876778","display_name":"Ana P. Vivancos","orcid":"https://orcid.org/0000-0003-2888-6512","observed_orcids":["https://orcid.org/0000-0003-2888-6512"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Vivancos","raw_affiliation_strings":["Cancer Genomics Lab and Molecular Pathology Lab, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Lab and Molecular Pathology Lab, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087015760","display_name":"Rodrigo Dienstmann","orcid":"https://orcid.org/0000-0001-5997-318X","observed_orcids":["https://orcid.org/0000-0001-5997-318X"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rodrigo Dienstmann","raw_affiliation_strings":["Oncology Data Science Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Data Science Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082191671","display_name":"Teresa Mercade Macarulla","orcid":"https://orcid.org/0000-0002-5856-4082","observed_orcids":["https://orcid.org/0000-0002-5856-4082","https://orcid.org/0000-0002-1881-362X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Macarulla Mercade","raw_affiliation_strings":["Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"4119","last_page":"4119"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.7188000082969666,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.7188000082969666,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.21610000729560852,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.03909999877214432,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ampullary-carcinoma","display_name":"ampullary carcinoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/molecular-profiles","display_name":"molecular profiles","score":0.6880000233650208},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.847000002861023},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.8510000109672546},{"id":"https://openalex.org/keywords/erbb2-mutations","display_name":"ERBB2 mutations","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ctnnb1-mutation","display_name":"CTNNB1 mutation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/intestinal-subtype","display_name":"intestinal subtype","score":0.9980000257492065},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":0.9539999961853027},{"id":"https://openalex.org/keywords/rnf43","display_name":"RNF43","score":0.7009999752044678},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.9610000252723694},{"id":"https://openalex.org/keywords/chek2","display_name":"CHEK2","score":0.9900000095367432},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.8970000147819519},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pan-her-inhibitor","display_name":"pan-HER inhibitor","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8538597822189331},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8530047535896301},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.6239221096038818},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.555413544178009},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5000503063201904},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44817766547203064},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4432826638221741},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.42290446162223816},{"id":"https://openalex.org/C2780840399","wikidata":"https://www.wikidata.org/wiki/Q594066","display_name":"Ampulla of Vater","level":3,"score":0.41637760400772095},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3871120810508728},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.3392794728279114},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3176935017108917},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1035526692867279},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.4119","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.4119","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2508774475","https://openalex.org/W2793466636","https://openalex.org/W4377023340","https://openalex.org/W2195579112","https://openalex.org/W2335863134","https://openalex.org/W4317877710","https://openalex.org/W4410299243","https://openalex.org/W3212921562","https://openalex.org/W4387252803","https://openalex.org/W1512177425"],"abstract_inverted_index":{"4119":[0],"Background:":[1],"AVC":[2,63,80,92,292],"is":[3,293,324],"a":[4,294],"rare":[5,295],"type":[6,125,296],"of":[7,20,34,58,91,100,207,224,297,318,321],"cancer":[8,298],"with":[9,62,95,103,187,200,226,234,239,250,299],"dismal":[10],"prognosis":[11],"and":[12,30,45,93,137,190,202,237,254,261],"limited":[13],"therapeutic":[14,46],"options":[15],"due":[16],"to":[17,70,86,312,326],"the":[18,88,319],"lack":[19],"specific":[21],"clinical":[22,44,96,221],"trials.":[23],"Two":[24],"histologic":[25],"subtypes":[26,303],"predominate,":[27],"namely":[28],"pancreatobiliary":[29,127,182],"intestinal.":[31],"A":[32,315],"variety":[33],"molecular":[35,89,306],"alterations":[36,307],"have":[37,48],"been":[38,50],"described":[39],"in":[40,52,65,78,128,133,139,148,159,165,171,177,194,218],"AVC,":[41,104],"but":[42],"their":[43],"implications":[47],"not":[49,280],"studied":[51],"detail.":[53],"Methods:":[54],"Retrospective":[55],"cohort":[56],"study":[57],"patients":[59],"(pts)":[60],"diagnosed":[61],"treated":[64],"our":[66],"institution":[67],"from":[68],"2010":[69],"2018.":[71],"We":[72,143],"routinely":[73],"performed":[74],"Next":[75],"Generation":[76],"Sequencing":[77],"all":[79],"tumors.":[81],"Our":[82],"main":[83],"objectives":[84],"were":[85,107,216],"describe":[87],"profile":[90,231],"correlate":[94],"outcomes.":[97,329],"Results:":[98],"Out":[99],"26":[101],"pts":[102,106,116,130,135,150,161,167,173,179,215,249],"13":[105],"male":[108],"(50%),":[109],"median":[110,277],"age":[111],"65":[112],"(range":[113],"43-83),":[114],"7":[115,134],"(27%)":[117,136],"had":[118,210],"stage":[119,251,265],"IV":[120,266],"disease":[121,256,267],"at":[122,268],"diagnosis.":[123],"Histologic":[124],"was":[126,245,279],"18":[129],"(69%),":[131],"intestinal":[132,195,208],"mixed":[138],"one":[140],"case":[141],"(4%).":[142],"identified":[144],"KRAS":[145,283],"mutations":[146],"(mut)":[147],"10":[149],"(7":[151],"pancreatobiliary,":[152],"2":[153,223],"intestinal,":[154],"1":[155],"mixed),":[156],"TP53":[157,285],"mut":[158,164,170,176,233],"6":[160],"(4/1/1),":[162],"PIK3CA":[163],"3":[166,172,178],"(3/0/0),":[168],"ERBB2":[169],"(2/1/0),":[174],"CTNNB1":[175],"(2/1/0).":[180],"In":[181,274],"we":[183,196],"found":[184,197],"single":[185,198],"cases":[186,199],"RNF43,":[188],"BRCA1":[189],"CHEK2":[191],"mut;":[192],"while":[193],"NRAS":[201],"BRAF":[203],"mut.":[204],"One":[205],"tumor":[206,230],"subtype":[209],"microsatellite":[211],"instability":[212],"(MSI).":[213],"Three":[214],"included":[217],"phase":[219],"I":[220],"trials,":[222],"them":[225],"trials":[227],"based":[228],"on":[229,282],"(ERBB2":[232],"pan-HER":[235],"inhibitor":[236],"MSI":[238],"immunotherapy).":[240],"Median":[241],"overall":[242],"survival":[243],"(OS)":[244],"21":[246],"months":[247,263],"for":[248,264],"I,":[252],"II":[253],"III":[255],"(95%":[257,270],"CI":[258,271],"12.37-not":[259],"reached)":[260],"13.2":[262],"diagnosis":[269],"5.73-not":[272],"reached).":[273],"cox":[275],"models,":[276],"OS":[278],"dependent":[281],"or":[284,288],"mutation":[286],"status,":[287],"histological":[289,302],"subtypes.":[290],"Conclusions:":[291],"two":[300],"differentiated":[301],"harboring":[304],"unique":[305],"that":[308],"can":[309],"be":[310],"matched":[311],"investigational":[313],"therapies.":[314],"broader":[316],"knowledge":[317],"biology":[320],"these":[322],"tumors":[323],"needed":[325],"improve":[327],"patient":[328]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-06-07T00:00:00"}